Several cities across China, including Shanghai, Nanjing, Suzhou, Fuzhou, and Chengdu, have recently begun offering the human papillomavirus (人乳頭瘤病毒) vaccine to male residents. This development marks a significant step in expanding HPV prevention efforts beyond the female population. While HPV is often associated with cervical cancer in women, medical experts stress that vaccinating males plays a crucial role in reducing …